Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Gout Therapeutics Market
Gout Therapeutics Market Size
- Report ID: GMI10280
- Published Date: Jul 2024
- Report Format: PDF
Gout Therapeutics Market Size
Gout Theapeutics Market size was valued at around USD 2.6 billion in 2023 and is estimated to grow at 7.3% CAGR from 2024 to 2032. Gout therapeutics involves medications and treatments used to manage and treat gout, a type of inflammatory arthritis characterized by sudden, severe attacks of pain, redness, and tenderness in the joints, often affecting the big toe. The condition is caused by the accumulation of urate crystals in the joint, due to high levels of uric acid in the blood.
The rising incidence of gout is a significant driver for the market. For instance, according to a study published by National Center for Biotechnology Information in March 2024, the global incidence of gout in individuals aged 15–39 years was 145.19 per 100,000 population in 2019, that doubled in comparison to 1990. This underscores the growing demand for effective treatment options in the gout therapeutics market.
Furthermore, advancements in treatment options, rising awareness towards early gout diagnosis, rising geriatric population, and changes in diet and lifestyle are the promoting factors advancing the growth of the market.
| Report Attribute | Details |
|---|---|
| Base Year: | 2023 |
| Gout Therapeutics Market Size in 2023: | USD 2.6 Billion |
| Forecast Period: | 2024 – 2032 |
| Forecast Period 2024 – 2032 CAGR: | 7.3% |
| 2024 – 2032 Value Projection: | USD 4.8 Billion |
| Historical Data for: | 2021 – 2023 |
| No. of Pages: | 195 |
| Tables, Charts & Figures: | 280 |
| Segments covered: | Drug Class, Condition, Route of Administration, Distribution Channel, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Frequently Asked Questions (FAQ) :
Gout Therapeutics Market Scope
